Wird geladen...
Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody
Activating mutations in fibroblast growth factor receptor 3 (FGFR3) have been identified in multiple types of human cancer and in congenital birth defects. In human lung cancer, fibroblast growth factor 9 (FGF9), a high-affinity ligand for FGFR3, is overexpressed in 10% of primary resected non-small...
Gespeichert in:
Veröffentlicht in: | Dis Model Mech |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
The Company of Biologists Ltd
2016
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4892666/ https://ncbi.nlm.nih.gov/pubmed/27056048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1242/dmm.024760 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|